Catalyst Crew Technologies Corp. (CCTC) is a publicly reporting technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions. Through its wholly-owned operating subsidiary, LataMed AI Corp. , the company owns and operates an integrated AI analytics platform and telemedicine infrastructure serving Latin America.
LataMed AI Corp. holds issued patents for its core AI modules—CardioAI, PulmoAI, and NeuroAI—which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management. The platform combines AI-driven clinical decision support with a hybrid care coordination model that integrates telemedicine, home-based care, and diagnostic services.
CCTC is committed to regulatory transparency, corporate growth, and expanding access to technology-enabled healthcare across emerging markets.